Cargando…

Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo

BACKGROUND: Exosomes derived from tumor cells (TEXs) are involved in both immune suppression, angiogenesis, metastasis and anticancer stimulatory, but the biological characteristics and role of diffuse large B cell lymphoma (DLBCL)-derived exosomes have been less investigated. METHODS: Exosomes (EXO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhenzhen, You, Liangshun, Wang, Lei, Huang, Xianbo, Liu, Hui, Wei, Ju ying, Zhu, Li, Qian, Wenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090784/ https://www.ncbi.nlm.nih.gov/pubmed/30103789 http://dx.doi.org/10.1186/s13046-018-0863-7

Ejemplares similares

Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients
por: Nydegger, Anna, et al.
Publicado: (2021)

Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors
por: Wang, Liangbo, et al.
Publicado: (2023)

The Potential Dual Role of H2.0-like Homeobox in the Tumorgenesis and Development of Colorectal Cancer and Its Prognostic Value
por: Chen, Shuo, et al.
Publicado: (2023)

PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242
por: Yang, Chunmei, et al.
Publicado: (2017)

Epithelial-Mesenchymal Transition Is a Critical Step in Tumorgenesis of Pancreatic Neuroendocrine Tumors
por: Fendrich, Volker, et al.
Publicado: (2012)

IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL
por: Li, Han-Bing, et al.
Publicado: (2023)

Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model
por: Zahavi, Tamar, et al.
Publicado: (2015)

Osteosarcoma Cell-Derived Exosomal miR-1307 Promotes Tumorgenesis via Targeting AGAP1
por: Han, Fei, et al.
Publicado: (2021)

Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis
por: Wang, Hongdan, et al.
Publicado: (2023)

TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC
por: Tang, Bufu, et al.
Publicado: (2023)

New indications and platforms for CAR‐T therapy in lymphomas beyond DLBCL
por: Iqbal, Madiha, et al.
Publicado: (2021)

In vitro synthesis of uniform poly(dG)–poly(dC) by Klenow exo(−) fragment of polymerase I
por: Kotlyar, Alexander B., et al.
Publicado: (2005)

Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling
por: Zhao, Xiaofeng, et al.
Publicado: (2017)

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study
por: Schubert, Maria-Luisa, et al.
Publicado: (2023)

The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023)

Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specified
por: Itami, Hiroe, et al.
Publicado: (2021)

ERG11 Gene Mutations and MDR1 Upregulation Confer Pan-Azole Resistance in Candida tropicalis Causing Disseminated Candidiasis in an Acute Lymphoblastic Leukemia Patient on Posaconazole Prophylaxis
por: You, Liangshun, et al.
Publicado: (2017)

Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter’s Trans-Formed DLBCL and Germinal Center B-Cells
por: Uhl, Barbara, et al.
Publicado: (2022)

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
por: Zhang, Wenqi, et al.
Publicado: (2021)

Lymphoma Microenvironment in DLBCL and PTCL-NOS: the key to uncovering heterogeneity and the potential for stratification
por: Miyawaki, Kohta, et al.
Publicado: (2022)

Diffuse Large B-Cell Lymphoma (DLBCL) in an Aged Raccoon (Procyon lotor)
por: D’Annunzio, Giulia, et al.
Publicado: (2022)

A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction
por: Ceccato, Jessica, et al.
Publicado: (2022)

Check'-ing DLBCL
por: Salaverria, Itziar, et al.
Publicado: (2015)

DLBCL Coast to Coast
por: Tesio, Melania
Publicado: (2018)

GOALs in relapsed DLBCL
por: Rösler, Wiebke, et al.
Publicado: (2022)

Shikonin exerts antitumor activity in Burkitt’s lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin
por: Ni, Fan, et al.
Publicado: (2018)

Role of Radiation Therapy in Mortality among Adolescents and Young Adults with Lymphoma: Differences According to Cause of Death
por: Yin, Xuejiao, et al.
Publicado: (2022)

Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran
por: Azimi, Somayeh, et al.
Publicado: (2016)

S5-KL-1 CURRENT TREATMENT FOR DLBCL AND PROPHYLAXIS AND TREATMENT FOR SECONDARY CNS LYMPHOMA
por: Izutsu, Koji
Publicado: (2019)

Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
por: Markers, Disease
Publicado: (2023)

Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo
por: Cattepoel, Susann, et al.
Publicado: (2016)

miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer
por: Liu, Xiaomin, et al.
Publicado: (2022)

Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
por: Griffiths, Robert, et al.
Publicado: (2010)

Survivin expression in patients with newly diagnosed nodal diffuse large B cell lymphoma (DLBCL)
por: Markovic, O., et al.
Publicado: (2012)

Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
por: Feng, Pengcheng, et al.
Publicado: (2021)

Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options
por: Vodicka, Prokop, et al.
Publicado: (2022)

MutLγ promotes repeat expansion in a Fragile X mouse model while EXO1 is protective
por: Zhao, Xiaonan, et al.
Publicado: (2018)

Simultaneous enhancement of the beta–exo synergism and exo–exo synergism in Trichoderma reesei cellulase to increase the cellulose degrading capability
por: Fang, Hao, et al.
Publicado: (2019)

Derepressing of STAT3 and USP7 contributes to resistance of DLBCL to EZH2 inhibition
por: He, Chenyun, et al.
Publicado: (2023)

Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor in vitro and in vivo
por: Zhou, Zhen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fd0n84fc64gebkraft9brfn6hp